PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, ("Seaport") a ...

Seaport names Lauren White as CFO. Ms. White most recently served as CFO at ImmunoGen prior to its acquisition by AbbVie for ...

Ms. White brings over 22 years of corporate finance, accounting, strategic partnering and investor relations expertise ... acquisition of the company by AbbVie. Additionally, Ms. White helped ...

prior to its acquisition by AbbVie (NYSE: ABBV) for $10.1 billion in 2024. Former ImmunoGen CFO will join Seaport to steer capital financing strategy, accounting, FP&A and investor relations ...

prior to its acquisition by AbbVie (NYSE: ABBV) for $10.1 billion in 2024. Former ImmunoGen CFO will join Seaport to steer capital financing strategy, accounting, FP&A and investor relations BOSTON, ...

Q3 2024 Earnings Call Transcript October 30, 2024 AbbVie Inc. beats earnings expectations. Reported EPS is $3, expectations ...

Welcome to the AbbVie Third Quarter 2024 Earnings Conference ... I would now like to introduce Ms. Liz Shea, Senior Vice President, Investor Relations. Good morning and thanks for joining us.

Royalty Pharma inaugural Prize for Impact in Healthcare awarded to Michael Milken, the founder of the Milken Institute, Faster Cures & the ...